Equities

Hanshang Group Co Ltd

600774:SHH

Hanshang Group Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)7.52
  • Today's Change-0.39 / -4.93%
  • Shares traded5.04m
  • 1 Year change-27.27%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Hanshang Group Co Ltd, formerly Wuhan Hanshang Group Co Ltd is a China-based company principally engaged in the retail of commodities. The Company is also engaged in the exhibition business, hotel business, tourism business and property management business. The Company mainly operates its retail business through department stores, shopping malls and specialty stores. The Company mainly operates 21st Century Shopping Mall, Ginza Mall and Wuzhan Shopping Center.

  • Revenue in CNY (TTM)1.28bn
  • Net income in CNY-5.18m
  • Incorporated1990
  • Employees2.38k
  • Location
    Hanshang Group Co LtdNo. 134, Hanyang AvenueWUHAN 430050ChinaCHN
  • Phone+86 2 768849191
  • Fax+86 2 784842384
  • Websitehttp://www.whhsg.com
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Shanghai Serum Bio-Technology Co Ltd197.30m50.92m2.17bn321.0042.611.95--11.000.47060.47061.8210.300.17351.143.91614,647.904.4810.434.5610.8476.6080.5425.8132.5742.72--0.00464.939.145.67-39.54-1.6213.07--
Shanghai Shen Lian Biomedical Corp310.36m-19.73m2.27bn380.00--1.55--7.30-0.048-0.0480.75583.560.19441.160.9692816,747.00-1.485.39-1.585.8460.6677.45-7.6225.485.14--0.001238.49-8.251.85-48.41-18.4910.47--
Hanshang Group Co Ltd1.28bn-5.18m2.33bn2.38k--1.36--1.83-0.016-0.0164.315.800.3622.528.04536,620.30-0.44512.00-0.75013.8953.6057.24-1.234.890.26881.180.316315.030.18935.14-32.2425.6212.88--
Data as of Nov 22 2024. Currency figures normalised to Hanshang Group Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

0.13%Per cent of shares held by top holders
HolderShares% Held
E Fund Management Co., Ltd.as of 30 Jun 2024181.60k0.08%
Bosera Asset Management Co., Ltd.as of 30 Jun 202496.40k0.04%
China Southern Asset Management Co., Ltd.as of 30 Jun 202415.40k0.01%
China Universal Asset Management Co., Ltd.as of 30 Jun 20242.70k0.00%
Guotai Asset Management Co., Ltd.as of 30 Jun 2024900.000.00%
Cinda Fund Management Co. Ltd.as of 30 Jun 20240.000.00%
HFT Investment Management Co., Ltd.as of 30 Jun 20240.000.00%
Harvest Fund Management Co., Ltd.as of 30 Jun 20240.000.00%
Penghua Fund Management Co., Ltd.as of 30 Jun 20240.000.00%
Everbright PGIM Fund Management Co. Ltd.as of 30 Jun 20240.000.00%
More ▼
Data from 30 Jun 2024 - 11 Nov 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.